Facebook
Twitter
LinkedIn
ForwardEarly-Career Investigators Showcase (2020)
Available on Saturday, July 11:
This on-demand webcast is dedicated to the work of some of the best and brightest new investigators in urology, showcasing their discoveries in high-impact basic, translational, and clinical research. Participants are nominated by AUA Sections, sub-specialty societies, or members of the AUA Board of Directors or AUA Research Council and Committees. Ten nominees have been selected by a peer-review panel to present their research via webcast presentations, and digital scientific posters from all nominees are available for viewing.
Registration Fees
| Member Category |
|
|---|---|
| AUA Member | Free |
| AUA Non-Member | Free |
Target Audience
- Physician scientists
- Researchers
- Clinical fellows
- Postdoctoral fellows
- Residents
- Medical/graduate students
Presentations
| Welcome and Introductions | Carolyn J.M. Best, PhD Director of Research, American Urological Association |
| An Investigation of the Physiology of Ureteral Contraction and the Adverse Effects of Stent Placement | Kymora B. Scotland, MD, PhD University of California Los Angeles |
| Abiraterone and enzalutamide are less effective when administered after long-term androgen deprivation therapy in a novel castration-resistant prostate cancer cellular model. | Ignacio Puche-Sanz, MD, PhD Hospital Universitario Virgen de las Nieves, Spain |
| Testosterone and Estrogen Supplementation Reverse Urethral Atrophy in Hypogonadal Rats | Matthias D. Hofer, MD, PhD Northwestern University |
| Molecular Subtype in MIBC is Driven by Sex-Specific Differences | Sima P. Porten, MD, MPH, FACS University of California San Francisco |
| CHD1-loss Promotes Tumor Heterogeneity and Antiandrogen Resistance | Ping Mu, PhD University of Texas Southwestern |
| Phosphatidylserine as a Biomarker of Sperm Vitality and Fertilization Competency | Ryan P. Smith, MD University of Virginia |
| Assessing the impact of telehealth insurance reform on telehealth utilization | Chad Ellimoottil, MD, MS University of Michigan |
| Disparities in Use of Pre-Biopsy Prostate MRI for Medicare-Eligible Prostate Cancer Patients | Christopher P. Filson, MD, MS Emory University |
| Employing Multiparametric Profiling to Characterize Immunotherapy Responders in Clear Cell Renal Cell Carcinoma | Brandon J. Manley, MD Moffitt Cancer Center |
Digital Posters
| Polymorphisms in the SLC13A2 (NaDC1) and SLC13A3 (NaDC3) genes in patients with kidney stones | Mario Basulto-Martinez, MD, MSc Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Mexico |
| Access to Care is a Key Determinant for Race-Based Differences in Prostate Cancer Outcomes | Alexander P. Cole, MD Brigham and Women’s Hospital |
| Assessing the impact of telehealth insurance reform on telehealth utilization | Chad Ellimoottil, MD, MS University of Michigan |
| Disparities in Use of Pre-Biopsy Prostate MRI for Medicare-Eligible Prostate Cancer Patients | Christopher P. Filson, MD, MS Emory University |
| Testosterone and Estrogen Supplementation Reverses Urethral Atrophy in Hypogonadal Rats | Matthias D. Hofer, MD, PhD Northwestern University |
| KDM6A acts as a tumor suppressor in bladder cancer by functioning as a co‐activator for FOXA1 | Byron H. Lee, MD, PhD Cleveland Clinic |
| Gender Impact on Bladder-Related Outcomes and Quality of Life after Paraplegic Spinal Cord Injury | Sara M. Lenherr, MD, MS, FPMRS University of Utah |
| Reconnaissance of Tumor Immune Microenvironment Spatial Heterogeneity in Metastatic Clear Cell Renal Cell Carcinoma and Correlation with Response to Immunotherapy | Brandon J. Manley, MD Moffitt Cancer Center |
| Loss of CHD1 Promotes Cancer Heterogeneity and Lineage Plasticity to Escape AR Targeted Therapy in Metastatic Prostate Cancer | Ping Mu, PhD University of Texas Southwestern |
| Quantification of Personalized Risk and Resilience in Patients with Bladder Cancer | Sarah P. Psutka, MD, MSc University of Washington |
| Abiraterone and enzalutamide are less effective when administered after long-term androgen deprivation therapy in a novel castration-resistant prostate cancer cellular model. | Ignacio Puche-Sanz, MD, PhD Hospital Universitario Virgen de las Nieves, Spain |
| Posphatidylserine (PtdSer) as a Biomarker of Sperm Vitality and Fertilization Competency | Ryan P. Smith, MD University of Virginia |
| Implementing a Fast Track Pathway for Microscopic Hematuria Referrals to the Urology Department | Kara L. Watts, MD Montefiore Medical Center |